The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 30 (6), 751-758
- https://doi.org/10.1016/0959-8049(94)90287-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer groupEuropean Journal of Cancer, 1993
- Disodium Pamidronate Identifies Differential Osteoclastic Bone Resorption in Metastatic Prostate CancerBJU International, 1992
- Morphometric Evidence for Bone Resorption and Replacement in Prostate CancerBJU International, 1991
- Carcinoma of the prostate. Hormonal therapyCancer, 1987
- Dichloromethylene-Diphosphonate in Patients with Prostatic Carcinoma Metastatic to the SkeletonJournal of Urology, 1985
- Generalised Increase in Bone Resorption in Carcinoma of the ProstateBJU International, 1985
- Spread of prostatic cancer to boneUrology, 1983
- Hormonal Therapy of Prostatic CancerCancer, 1980
- Prostatic CarcinomaThe New England Journal of Medicine, 1979
- Response of bone to tumor invasionCancer, 1956